Showing 6751-6760 of 8649 results for "".
- Outlook Therapeutics Presents Positive NORSE THREE Safety Data for Lytenava (bevacizumab-vikg)https://modernod.com/news/outlook-therapeutics-presents-positive-norse-three-safety-data-for-lytenava-bevacizumab-vikg-at-euretina/2479575/Outlook Therapeutics announced the presentation of safety data from the NORSE THREE trial evaluating ONS-5010/Lytenava (bevacizumab-vikg) at the EURETINA Virtual 2021 conference on September 12, 2021. The previously announced topline results from the open-label safety study demonstrated that
- New Contact Lens Update Focuses on Axial Length Measures in Myopia Managementhttps://modernod.com/news/new-contact-lens-update-focuses-on-axial-length-measures-in-myopia-management/2479488/Issue 61 of
- New Virtual Training Takes on Leading Cause of Childhood Blindnesshttps://modernod.com/news/new-virtual-training-takes-on-leading-cause-of-childhood-blindness/2479471/Orbis International, with support from Alcon, launched a new virtual Flying Eye Hospital project that will train eye care professionals across Latin America to treat retinopathy of prematurity (ROP), the leading cause of blindness among children worldwide. Affecti
- Market Scope: Phaco and FLACS Upgrades to Drive Expansion in Cataract Equipment Markethttps://modernod.com/news/market-scope-phaco-and-flacs-upgrades-to-drive-expansion-in-cataract-equipment-market/2479462/A number of market leaders in phaco and femtosecond cataract technology will launch upgraded platforms over the next year, which is expected to increase market penetration for both types of systems and stimulate the replacement of older models. Johnson & Johnson Vision has introduced i
- PRECISIONeffect Acquires Pascāle Communicationshttps://modernod.com/news/precisioneffect-acquires-pascale-communications/2479440/
- Illinois Tech Researcher Awarded $2.5 Million Grant to Prevent Vision Loss in Diabetes Patientshttps://modernod.com/news/illinois-tech-researcher-awarded-2-5-million-grant-to-prevent-vision-loss-in-diabetes-patients/2479432/Illinois Institute of Technology Professor of Biomedical Engineering Jennifer Kang-Mieler, PhD. has received a second research project grant (R01) from the National Institutes of Health to study diabetic retinopathy.
- IrisVision Names Naeem Kayani President & Chief Operating Officerhttps://modernod.com/news/irisvision-names-naeem-kayani-president-chief-operating-officer/2479431/IrisVision announced the addition of Naeem Kayani to serve as President and Chief Operating Officer. Launched in 2017, IrisVision’s flagship consumer product employs breakthrough, smart software lens technology that leverages functional areas of the eyes to restore vision instantly. Design
- Nickelodeon and OneSight Team Up for Kids Eye Health Campaignhttps://modernod.com/news/nickelodeon-and-onesight-team-up-for-kids-eye-health-campaign/2479424/More than 230 million kids around the world under the age of 15 lack access to the glasses they need. To make a positive impact on kids’ eye health globally, Nickelodeon International’s “Together for Good” and OneSight, a global vision nonprofit, announced their partnership on a new, multi-territ
- Monty Montoya Appointed CEO of TherOptixhttps://modernod.com/news/monty-montoya-appointed-ceo-of-theroptix/2479395/Monty Montoya has been named chief executive officer of TherOptix, a preclinical biopharma company focused on delivering clinically impactful therapeutics via a drug-eluting contact lens platform. TherOptix has received orphan drug designation on its lead candidate (001) for prevention of prolife
- Zeiss Introduces Fully Integrated, Data-Driven Medical Ecosystemhttps://modernod.com/news/zeiss-introduces-fully-integrated-data-driven-medical-ecosystem/2479366/During a virtual press conference on Tuesday, Zeiss announced the launch of a new medical ecosystem. The ecosyste